UK health secretary Matt Hancock (File Photo)
UK health secretary Matt Hancock (File Photo)

'Britons should be confident': Govt assures on Covid jab monitoring system

British health secretary Matt Hancock's assurance comes after the vaccine advisory committee suggested on Wednesday that an alternative to Oxford-AstraZeneca's vaccine should be given to under 30s where possible due to a "vanishingly" rare side effect of blood clots in the brain.
Reuters |
PUBLISHED ON APR 08, 2021 02:21 PM IST

Britons should be confident that the system to monitor COVID-19 vaccines is working following the change in advice on giving young people the Oxford-AstraZeneca jab, Health Secretary Matt Hancock said on Thursday.

"People can be reassured that we have the high class safety system run by our world class regulator (...) and then we're totally transparent with all of the side effects, no matter how extremely rare they are like these ones," he told Sky News.

Britain's vaccine advisory committee said on Wednesday that an alternative to Oxford-AstraZeneca's vaccine should be given to under 30s where possible due to a "vanishingly" rare side effect of blood clots in the brain.

Hancock said new guidance would not delay Britain's vaccination programme because alternatives from Pfizer and Moderna would be available for the affected group.

Britain is aiming to give a first dose of COVID-19 vaccine all over-50s by mid-April and all adults by the end of July.

Hancock said there were 10.16 million people aged between 18 to 29, of whom 1.6 million had already had a first dose of vaccine.

"We have more than enough Pfizer and Moderna vaccines to cover all of the remaining eight and a half million people," he said.

"We are on track to hit the target that we've set that we will ensure every adult in the UK is offered the jab by the end of July."

SHARE THIS ARTICLE ON

Related Stories

In March, more than a dozen countries, mostly in Europe, suspended their use of AstraZeneca over the blood clot issue.(AP file photo)
In March, more than a dozen countries, mostly in Europe, suspended their use of AstraZeneca over the blood clot issue.(AP file photo)

UK advises limiting AstraZeneca vaccine in under-30s amid blood clot worry

AP | | Posted by Harshit Sabarwal
PUBLISHED ON APR 08, 2021 03:43 AM IST
The recommendation came as regulators in the United Kingdom and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people — even though the European Medicines Agency said it had found a “possible link” between the shot and the rare clots.
For those under 30, the immediately available alternative to AstraZeneca is the Pfizer-BioNtech vaccine, which has been in circulation since December.(Reuters file photo)
For those under 30, the immediately available alternative to AstraZeneca is the Pfizer-BioNtech vaccine, which has been in circulation since December.(Reuters file photo)

UK govt insists vaccine program on track despite AstraZeneca restriction

Bloomberg | | Posted by Harshit Sabarwal
PUBLISHED ON APR 07, 2021 11:39 PM IST
The Medicines and Healthcare products Regulatory Agency said 79 people among the more than 20 million who have received the Astra shot in Britain had suffered rare blood clots, 19 of whom had died. But while it found a “reasonably plausible link” to the vaccine, it did not block its usage.
Elle Taylor (L), 24, an unpaid carer from Ammanford, receives an injection of the Moderna Covid-19 vaccine in Wales.(AFP)
Elle Taylor (L), 24, an unpaid carer from Ammanford, receives an injection of the Moderna Covid-19 vaccine in Wales.(AFP)

UK to offer non-AstraZeneca Covid-19 vaccine to under-30s over blood clot link

Bloomberg |
UPDATED ON APR 07, 2021 08:36 PM IST
In its latest recommendation, the European Medicines Agency said that “unusual blood clots with low blood platelets should be listed as very rare side effects.”
Close
SHARE
Story Saved
OPEN APP